<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
58933-391-12
</NDCCode>
<PackageDescription>
1 BOTTLE in 1 CARTON (58933-391-12) / 12 TABLET in 1 BOTTLE
</PackageDescription>
<NDC11Code>
58933-0391-12
</NDC11Code>
<ProductNDC>
58933-391
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Pepto-bismol
</ProprietaryName>
<ProprietaryNameSuffix>
Diarrhea
</ProprietaryNameSuffix>
<NonProprietaryName>
Bismuth Subsalicylate
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20180301
</StartMarketingDate>
<EndMarketingDate>
20260630
</EndMarketingDate>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M008
</ApplicationNumber>
<LabelerName>
Procter & Gamble Manufacturing M�xico, S. de R.L. de C.V.
</LabelerName>
<SubstanceName>
BISMUTH SUBSALICYLATE
</SubstanceName>
<StrengthNumber>
525
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2024-10-12
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20190301
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20260630
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>